Press "Enter" to skip to content

New patent for Astrazeneca Pharms drug BEVESPI AEROSPHERE

2
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug BEVESPI AEROSPHERE

Annual Drug Patent Expirations for BEVESPI+AEROSPHERE
Annual Drug Patent Expirations for BEVESPI+AEROSPHERE

Bevespi Aerosphere is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.

This drug has one hundred and thirty-two patent family members in thirty countries.

The generic ingredient in BEVESPI AEROSPHERE is formoterol fumarate; glycopyrrolate. One supplier is listed for this compound. Additional details are available on the formoterol fumarate; glycopyrrolate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug BEVESPI AEROSPHERE

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!